CN104597008A - Homocysteine kit based on aptamer fluorescent probe HCy3 and detection method thereof - Google Patents
Homocysteine kit based on aptamer fluorescent probe HCy3 and detection method thereof Download PDFInfo
- Publication number
- CN104597008A CN104597008A CN201410717094.4A CN201410717094A CN104597008A CN 104597008 A CN104597008 A CN 104597008A CN 201410717094 A CN201410717094 A CN 201410717094A CN 104597008 A CN104597008 A CN 104597008A
- Authority
- CN
- China
- Prior art keywords
- homocysteine
- nucleic acid
- acid aptamer
- fluorescence probe
- aptamer fluorescence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 title claims abstract description 138
- 108091023037 Aptamer Proteins 0.000 title claims abstract description 26
- 238000001514 detection method Methods 0.000 title claims abstract description 22
- 239000007850 fluorescent dye Substances 0.000 title abstract description 4
- 239000000523 sample Substances 0.000 claims abstract description 122
- 210000004369 blood Anatomy 0.000 claims abstract description 40
- 239000008280 blood Substances 0.000 claims abstract description 40
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 30
- 239000000203 mixture Substances 0.000 claims abstract description 30
- 102000002322 Egg Proteins Human genes 0.000 claims abstract description 24
- 108010000912 Egg Proteins Proteins 0.000 claims abstract description 24
- 210000004681 ovum Anatomy 0.000 claims abstract description 24
- 238000000034 method Methods 0.000 claims abstract description 23
- 239000004615 ingredient Substances 0.000 claims abstract description 3
- 108091008104 nucleic acid aptamers Proteins 0.000 claims description 63
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 claims description 42
- 230000005284 excitation Effects 0.000 claims description 30
- 238000012360 testing method Methods 0.000 claims description 26
- 239000007788 liquid Substances 0.000 claims description 23
- 239000012530 fluid Substances 0.000 claims description 22
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 claims description 21
- 239000008363 phosphate buffer Substances 0.000 claims description 19
- 238000002156 mixing Methods 0.000 claims description 15
- 239000007983 Tris buffer Substances 0.000 claims description 14
- 239000000178 monomer Substances 0.000 claims description 14
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 14
- 239000006228 supernatant Substances 0.000 claims description 13
- 238000005336 cracking Methods 0.000 claims description 12
- 239000000539 dimer Substances 0.000 claims description 11
- 210000005259 peripheral blood Anatomy 0.000 claims description 11
- 239000011886 peripheral blood Substances 0.000 claims description 11
- 230000005477 standard model Effects 0.000 claims description 11
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 10
- 239000003146 anticoagulant agent Substances 0.000 claims description 10
- 229940127219 anticoagulant drug Drugs 0.000 claims description 10
- 230000005281 excited state Effects 0.000 claims description 10
- 229960002897 heparin Drugs 0.000 claims description 10
- 229920000669 heparin Polymers 0.000 claims description 10
- 239000002773 nucleotide Substances 0.000 claims description 9
- 125000003729 nucleotide group Chemical group 0.000 claims description 9
- 230000008859 change Effects 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 239000012634 fragment Substances 0.000 claims description 2
- 238000001685 time-resolved fluorescence spectroscopy Methods 0.000 claims description 2
- 210000003743 erythrocyte Anatomy 0.000 abstract description 10
- 238000012545 processing Methods 0.000 abstract description 2
- 230000035945 sensitivity Effects 0.000 abstract description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 abstract 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 abstract 1
- 239000000872 buffer Substances 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 230000009089 cytolysis Effects 0.000 abstract 1
- 239000006166 lysate Substances 0.000 abstract 1
- 239000002075 main ingredient Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 description 9
- 238000009472 formulation Methods 0.000 description 9
- 238000004108 freeze drying Methods 0.000 description 9
- 229910021642 ultra pure water Inorganic materials 0.000 description 9
- 239000012498 ultrapure water Substances 0.000 description 9
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 239000013077 target material Substances 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 230000001351 cycling effect Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 239000003068 molecular probe Substances 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- QEDXSHCYPROEOK-UHFFFAOYSA-N 3-phosphanylpropanoic acid Chemical class OC(=O)CCP QEDXSHCYPROEOK-UHFFFAOYSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 108091027568 Single-stranded nucleotide Proteins 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002875 fluorescence polarization Methods 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 230000005283 ground state Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000010339 medical test Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 201000010193 neural tube defect Diseases 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 208000035581 susceptibility to neural tube defects Diseases 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000004879 turbidimetry Methods 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention relates to a homocysteine HCy kit based on aptamer fluorescent probe, also relates to a method for determining homocysteine HCy concentration and determining reagent composition and ingredients, and belongs to the technical field of medical science examination determination. The main ingredients of the kit comprise an erythrocyte lysate, a phosphoric acid buffer PBS, a homocysteine HCy standard sample and a homocysteine HCy aptamer fluorescent probe. The concentration of homocysteine HCy is measured and calculated by performing blood sample lysis and mixed ovum culturing treatment, and combining with fluorospectrophotometer detection. The kit and the method have the advantages of simple sample processing, simple operation, short detection time, high detection specificity, high sensitivity, high detection result repeatability and the like.
Description
Technical field
The invention belongs to medical test determination techniques field, particularly relate to the homocysteine HCy kit based on nucleic acid aptamer fluorescence probe and detection method thereof.
Background technology
Homocysteine is a kind of sulfur-containing amino acid, is the intermediate product of Methionine metabolism in biosome, compared with halfcystine, and many methylene in side chain.Homocysteine is the risk factor of various diseases, and thinking that homocysteine increases at present is that atherosclerotic is cardiovascular and cerebrovascular diseases caused the most extensively, the strongest independently paathogenic factor.Homocysteine is also relevant with the impact of the various diseases such as neural tube defects, Parkinson's, senile dementia, chronic renal failure and some drugs, tumour.Detect the main chromatography of method of homocysteine, immunological method and Enzymatic cycling.
Chromatography: Gas Chromatography-Mass Spectrometry homocysteine.This method can the many kinds of substance such as Simultaneously test halfcystine, methionine, cystathionie and methylglycine.Chromatography is highly sensitive, specificity good, but sample preparation, separation condition, chromatographic column prepare all multi-Varis, makes it be difficult to standardization.And hplc device is expensive, technical conditions require high, needs special maintainer, makes its Difficulty.
Immunological Method: the anti-AdoHcy monoclonal technigue of this method application specific, adopts fluorescence polarization method or immunization to measure.Homocysteine, under SAH hydrolytic enzyme and excessive adenosine exist, is converted into SAH; The fluorescence SAH tracer of prediluted potpourri, anti-AdoHcy monoclonal antibody and mark is together hatched, and instrument detects the change of polarized light automatically, can measure sample total homocysteine level.Antibody fluorescence analytic approach and turbidimetry can not direct-detection Homocysteines, need just can go out result, complex operation step in more than one hour.
Enzymatic cycling; Be utilize zymolyte characteristic, amplify the detection method of target material (measured object).Blood plasma oxidized form homocysteine is reduced into sequestered homocysteine through three second carboxyethyl phosphines (TCEP), based on homocysteine methyltransgerase, the principle of the cyclophorase system that SAH hydrolytic enzyme is formed and dehydrogenase coenzyme system, decomposition product develops the color, and is worth the content of the homocysteine in blood plasma with automatic biochemistry analyzer at 600nm wavelength survey OD.
Not having at present can the antibody of Direct Recognition homocysteine and other molecular probe.Therefore design the molecular probe that a kind of height sets homocysteine, and based on this set up simple and quick and cheap detection method by improve to cardiovascular and cerebrovascular equal the relevant disease of homocysteine monitoring.
Aptamer is that the novel identification of a class that developed recently gets up divides, refer to can high specific and high-affinity region target molecule knot single stranded nucleotide acid molecule.Aptamer can pass through part index concentration phyletic evolution technology (SystematicEvolution of Ligands by ExponentialEnrichment, SELEX) screening and obtain.SELEX technology refers to that applied chemistry method synthesizes jumbo random oligonucleotide (being made up of the fixed sequence program at two ends and the random series of centre) library, by applying selection pressure (in conjunction with target, the process of elutriation and target high special binding fragment), and in conjunction with Amplification Technologies, through the circulation selective enrichment too much taken turns, obtain the oligonucleotide molecules be combined with target material high special, can be RNA also can be DNA, length be generally 25 ~ 60 nucleotide.Aptamer folds mainly through there is adaptability, is interacted by hydrogen bond, hydrophobic sedimentation, Van der Waals force and target molecule, forms stable three-D space structure with the target molecule of insertion or bag quilt.Aptamer not with target molecule in conjunction with time, aptamer is in more open structure, 5' and 3' dissociates at two ends mutually.With target molecule in conjunction with time, target molecule induction aptamer structure changes, 5' end and the 3' end of aptamer all will participate in the interaction with target molecule specific region (being similar to the antigen site be combined with antibody), cause 5' and 3' two ends close to each other.This feature makes aptamer be suitable for molecular beacon probe design.Wherein a kind of molecular beacon design make use of fluorescent dye pyrene molecule.Excited state dimer can be formed when an excited state pyrene molecule and another ground state pyrene molecule closely meet with time, a photon can be discharged in the position longer than pyrene monomer wavelength.Pyrene excited state dimer emission peak is 480 to 500nm, and the emission peak of pyrene monomer is between 370 to 400nm.In addition, the pyrene molecular fluorescence life-span is longer than the life-span of the non-specific fluorescence excitation in biological sample, after non-specific fluorescence excitation disappears, then can collect the dimeric fluorescence signal of excited state, greatly improve specificity and the sensitivity of detection during detection.Identify that the aptamer of homocysteine can be applied to the clinical detection of homocysteine, improve detection efficiency, reduce testing cost.
Aptamer is combined presented hypersensitivity and high specific with target material, it is made to have a good application prospect in medical diagnosis on disease, although clinical practice report ripe is at present less, but the research of applying fit detection target protein is on the increase, and also constantly occurs based on fit new detecting technique.Aptamer becomes a new generation for the molecular medicine of specific protein or targeting vector due to the chemical antibody characteristic of its uniqueness, and for detecting the target molecule material of its specific recognition.But the homocysteine HCy diagnostic reagent that is directed at present based on aptamer also lacks very much, and the exploitation being directed to the nucleic acid aptamer fluorescence probe detection kit of homocysteine HCy there is not yet report.
Summary of the invention
The object of the invention is for existing easy generation operative technique error, repeatability is not good enough, disturbing factor a lot, the high deficiency of complex operation, testing cost, provides a kind of homocysteine HCy kit based on nucleic acid aptamer fluorescence probe and detection method thereof.
The solution of the present invention is by realizing like this:
Based on a homocysteine kit for nucleic acid aptamer fluorescence probe, it is characterized in that, principal ingredient comprises: containing NH
4cl, Tris, EDTA-Na
2erythrocyte cracked liquid; Containing MgCl
20.2M phosphate buffer; Homocysteine standard items; Homocysteine nucleic acid aptamer fluorescence probe; Described homocysteine nucleic acid aptamer fluorescence probe is the nucleotide single-chain of 5' and 3' two ends difference mark fluorescent pyrene molecule monomer, and this nucleotide single-chain sequence is: ggcactgtac ggctaagttc ccggatagtggattggaact ggcataaccc.This sequence designations is HCy3.
Above-described a kind of homocysteine kit based on nucleic acid aptamer fluorescence probe, described containing NH
4cl, Tris, EDTA-Na
2erythrocyte cracked liquid for containing 1 ~ 280mmol/L NH
4cl, 1 ~ 34mmol/L Tris, 1 ~ 2mmol/LEDTA-Na
2, pH7.0 ~ 7.2; Described containing MgCl
20.2M phosphate buffer for containing 1 ~ 10mmol/L MgCl
2.
Arbitrary described a kind of homocysteine kit based on nucleic acid aptamer fluorescence probe, is characterized in that above, described containing NH
4cl, Tris, EDTA-Na
2erythrocyte cracked liquid, containing MgCl
20.2M phosphate buffer, homocysteine standard items, homocysteine nucleic acid aptamer fluorescence probe be the dry powder preparing the liquid reagent that directly uses or need before using to be dissolved in water.
Above-described a kind of homocysteine kit based on nucleic acid aptamer fluorescence probe, it is characterized in that, this kit is for detecting the homotype semicystinol concentration investigating in anticoagulant heparin whole blood or peripheral blood.
Detect a method for homotype semicystinol concentration investigating in order to upper arbitrary described homocysteine kit based on nucleic acid aptamer fluorescence probe, it is characterized in that, method step comprises:
(1) blood sample cracking: by blood sample with containing NH
4cl, Tris, EDTA-Na
2erythrocyte cracked liquid press the mixing of 1:0.5 ~ 5 volume ratios, leave standstill 5 ~ 30min, then medium-speed centrifuge 5 ~ 10min, collect supernatant;
(2) mixing ovum to educate: mixing ovum is educated: get 20 ~ 100 μ l steps 1) use of the supernatant that obtains and 30 ~ 50ul is containing MgCl
20.2M phosphate buffer, dissolve the homocysteine nucleic acid aptamer fluorescence probe reagent mixing that homocysteine nucleic acid aptamer fluorescence probe obtains, under room temperature, ovum educates 5 ~ 15min, homocysteine nucleic acid aptamer fluorescence probe is fully combined with blood sample, obtains test fluid;
(3) fluoroscopic examination: fluorescence detector detecting step 2) the test fluid 50ul that obtains, after fluorescence detector fluorescence excitation, to read after fluorescence excitation in 20 to the 100ns time period wavelength at the fluorescent value of 480 ~ 500nm;
(4) result calculates: use biomedical mapping software, with reference to the typical curve that homocysteine standard model makes, integrating step 3) in the fluorescent value that detects calculate the concentration of homocysteine in blood sample.
Above-described biomedical software is Sigma plot software, in buying on the market.
A kind of above-described method detecting homotype semicystinol concentration investigating with the homocysteine kit based on nucleic acid aptamer fluorescence probe, it is characterized in that, in described homocysteine nucleic acid aptamer fluorescence probe reagent, homocysteine nucleic acid aptamer fluorescence probe concentration is 200 ~ 400nmol/L, its characteristic is also, described homocysteine nucleic acid aptamer fluorescence probe is the nucleotide single-chain of 5' and 3' two ends difference mark fluorescent pyrene molecule monomer, this nucleotide single-chain sequence is: ggcactgtac ggctaagttcccggatagtg gattggaact ggcataaccc.
Homocysteine nucleic acid aptamer fluorescence probe not with homocysteine in conjunction with time, aptamer is in more open structure, and the pyrene molecule monomer at 5' and 3' two ends dissociates mutually, and after fluorescence excitation, emission wavelength is between 370 ~ 400nm; Homocysteine nucleic acid aptamer fluorescence probe and homocysteine in conjunction with time, homocysteine induces its recurring structure to change, the pyrene molecule monomer at aptamer 5' and 3' two ends is close to each other, form excited state dimer, after fluorescence excitation, excited state dimer emission wavelength is between 480 to 500nm.
A kind of above-described method detecting homotype semicystinol concentration investigating with the homocysteine kit based on nucleic acid aptamer fluorescence probe, it is characterized in that, described blood sample is anticoagulant heparin whole blood or peripheral blood, described containing NH
4cl, Tris, EDTA-Na
2erythrocyte cracked liquid for containing 1 ~ 280mmol/L NH
4cl, 1 ~ 34mmol/L Tris, 1 ~ 2mmol/LEDTA-Na
2, pH7.0 ~ 7.2; Described containing MgCl
20.2M phosphate buffer for containing 1 ~ 10mmol/L MgCl
2; Described fluorescence detector is the fluorescence detector with time-resolved fluorometry.
A kind of above-described method detecting homotype semicystinol concentration investigating with the homocysteine kit based on nucleic acid aptamer fluorescence probe, it is characterized in that, this detection method is for detecting the homotype semicystinol concentration investigating in anticoagulant heparin whole blood or peripheral blood.
Principle of the present invention is: when not with homocysteine, aptamer is in more open structure, and the pyrene molecule monomer at 5' and 3' two ends dissociates mutually, and fluorescence emission wavelengths is between 370 to 400nm; With homocysteine in conjunction with time, homocysteine induction aptamer structure changes, and the pyrene molecule monomer at 5' and the 3' two ends of aptamer is close to each other, and form dimer, pyrene excited state emission wavelength dimer is between 480 to 500nm.Pyrene excited state dimer fluorescence lifetime has and reaches 100ns, longer than the biological sample autofluorescence life-span (being about 5ns), by detecting the fluorescence intensity after homocysteine aptamer probe and sample mix and fluorescence lifetime, the concentration of homocysteine in calculation sample.
Substantive distinguishing features of the present invention and marked improvement are:
(1) detect fast simple to operate, without the need to complex sample processing and be separated, aptamer probe is directly added the blood sample liquid after cracking, with the fluorescent value that just can detect 480 ~ 500nm place in the fluorospectrophotometer short time;
(2) this kit and detection method thereof have highly sensitive, testing result repeatability is high, sample detection error is between 0.01 ~ 0.1%, high specificity, homocysteine nucleic acid aptamer fluorescence probe not with homocysteine in conjunction with time, aptamer is in more open structure, and the pyrene molecule monomer at 5' and 3' two ends dissociates mutually, and after fluorescence excitation, emission wavelength is between 370 ~ 400nm; Its with homocysteine in conjunction with time, homocysteine induces it to change, and the pyrene molecule monomer at aptamer 5' and 3' two ends is close to each other, and form dimer, after fluorescence excitation, dimer emission wavelength is between 480 ~ 500nm.
(3) reagent used can make to prepare the liquid reagent that can directly use or the dry powder used after being dissolved in water before using, and detecting reagent can storage at normal temperature, convenient transportation.
Embodiment
Below in conjunction with table 1 and embodiment, the homocysteine HCy kit and the detection method thereof that the present invention is based on nucleic acid aptamer fluorescence probe are described.
Kit reagent in table 1. embodiment becomes to be grouped into
Embodiment 1
After agent formulations dissolving prepares needed for embodiment in table 11, be distributed into bottle, carry out freeze drying, make powdered reagent; Before using, add ultrapure water, use after redissolving.Each sample set 3 parallel, detecting step is as follows:
(1) blood sample cracking: by the 1:0.5 mixing by volume of anticoagulant heparin whole blood, erythrocyte cracked liquid, leave standstill 30min, then medium-speed centrifuge 7min, collect supernatant;
(2) mix ovum to educate: get 20 μ l steps 1) the dissolving with 0.2M phosphate buffer the homocysteine nucleic acid aptamer fluorescence probe reagent that homocysteine nucleic acid aptamer fluorescence probe obtains and mix of the upper cleer and peaceful 45ul that obtains, under room temperature, ovum educates 5min, obtains test fluid;
(3) fluoroscopic examination: fluorescence detector detecting step 2) the test fluid 50ul that obtains, after fluorescence detector fluorescence excitation, to read after fluorescence excitation in 20 to the 100ns time period wavelength at the fluorescent value of 480 ~ 500nm;
(4) result calculates: use biomedical mapping software, with reference to the typical curve that homocysteine standard model makes, integrating step 3) in the fluorescent value that detects calculate the concentration of homocysteine in blood sample.
3 replicate determination errors of sample are 0.05 ± 0.01%.
Embodiment 2
After agent formulations dissolving prepares needed for embodiment in table 12, be distributed into bottle, carry out freeze drying, make powdered reagent; Before using, add ultrapure water, use after redissolving.Each sample set 3 parallel, detecting step is as follows:
(1) blood sample cracking: by the 1:2.5 mixing by volume of peripheral blood, erythrocyte cracked liquid, leave standstill 5min, then medium-speed centrifuge 6min, collect supernatant;
(2) mix ovum to educate: get 50 μ l steps 1) the dissolving with 0.2M phosphate buffer the homocysteine nucleic acid aptamer fluorescence probe reagent that homocysteine nucleic acid aptamer fluorescence probe obtains and mix of the upper cleer and peaceful 30ul that obtains, under room temperature, ovum educates 6min, obtains test fluid;
(3) fluoroscopic examination: fluorescence detector detecting step 2) the test fluid 50ul that obtains, after fluorescence detector fluorescence excitation, to read after fluorescence excitation in 20 to the 100ns time period wavelength at the fluorescent value of 480 ~ 500nm;
(4) result calculates: use biomedical mapping software, with reference to the typical curve that homocysteine standard model makes, integrating step 3) in the fluorescent value that detects calculate the concentration of homocysteine in blood sample.3 replicate determination errors of sample are 0.02 ± 0.01%.
Embodiment 3
After agent formulations dissolving prepares needed for embodiment in table 13, be distributed into bottle, carry out freeze drying, make powdered reagent; Before using, add ultrapure water, use after redissolving.Each sample set 3 parallel, detecting step is as follows:
(1) blood sample cracking: by the 1:3.5 mixing by volume of peripheral blood, erythrocyte cracked liquid, leave standstill 10min, then medium-speed centrifuge 5min, collect supernatant;
(2) mix ovum to educate: get 75 μ l steps 1) the dissolving with 0.2M phosphate buffer the homocysteine nucleic acid aptamer fluorescence probe reagent that homocysteine nucleic acid aptamer fluorescence probe obtains and mix of the upper cleer and peaceful 45ul that obtains, under room temperature, ovum educates 7min, obtains test fluid;
(3) fluoroscopic examination: fluorescence detector detecting step 2) the test fluid 50ul that obtains, after fluorescence detector fluorescence excitation, to read after fluorescence excitation in 20 to the 100ns time period wavelength at the fluorescent value of 480 ~ 500nm;
(4) result calculates: use biomedical mapping software, with reference to the typical curve that homocysteine standard model makes, integrating step 3) in the fluorescent value that detects calculate the concentration of homocysteine in blood sample.
3 replicate determination errors of sample are 0.04 ± 0.01%.
Embodiment 4
After agent formulations dissolving prepares needed for embodiment in table 14, be distributed into bottle, carry out freeze drying, make powdered reagent; Before using, add ultrapure water, use after redissolving.Each sample set 3 parallel, detecting step is as follows:
(1) blood sample cracking: by the 1:0.5 mixing by volume of anticoagulant heparin whole blood, erythrocyte cracked liquid, leave standstill 25min, then medium-speed centrifuge 8min, collect supernatant;
(2) mix ovum to educate: get 100 μ l steps 1) the dissolving with 0.2M phosphate buffer the homocysteine nucleic acid aptamer fluorescence probe reagent that homocysteine nucleic acid aptamer fluorescence probe obtains and mix of the upper cleer and peaceful 50ul that obtains, under room temperature, ovum educates 8min, obtains test fluid;
(3) fluoroscopic examination: fluorescence detector detecting step 2) the test fluid 50ul that obtains, after fluorescence detector fluorescence excitation, to read after fluorescence excitation in 20 to the 100ns time period wavelength at the fluorescent value of 480 ~ 500nm;
(4) result calculates: use biomedical mapping software, with reference to the typical curve that homocysteine standard model makes, integrating step 3) in the fluorescent value that detects calculate the concentration of homocysteine in blood sample.
3 replicate determination errors of sample are 0.06 ± 0.01%.
Embodiment 5
After agent formulations dissolving prepares needed for embodiment in table 15, be distributed into bottle, carry out freeze drying, make powdered reagent; Before using, add ultrapure water, use after redissolving.Each sample set 3 parallel, detecting step is as follows:
(1) blood sample cracking: by the 1:1.0 mixing by volume of anticoagulant heparin whole blood, erythrocyte cracked liquid, leave standstill 20min, then medium-speed centrifuge 9min, collect supernatant;
(2) mix ovum to educate: get 80 μ l steps 1) the dissolving with 0.2M phosphate buffer the homocysteine nucleic acid aptamer fluorescence probe reagent that homocysteine nucleic acid aptamer fluorescence probe obtains and mix of the upper cleer and peaceful 30ul that obtains, under room temperature, ovum educates 9min, obtains test fluid;
(3) fluoroscopic examination: fluorescence detector detecting step 2) the test fluid 50ul that obtains, after fluorescence detector fluorescence excitation, to read after fluorescence excitation in 20 to the 100ns time period wavelength at the fluorescent value of 480 ~ 500nm;
(4) result calculates: use biomedical mapping software, with reference to the typical curve that homocysteine standard model makes, integrating step 3) in the fluorescent value that detects calculate the concentration of homocysteine in blood sample.
3 replicate determination errors of sample are 0.07 ± 0.01%.
Embodiment 6
After agent formulations dissolving prepares needed for embodiment in table 16, be distributed into bottle, carry out freeze drying, make powdered reagent; Before using, add ultrapure water, use after redissolving.Each sample set 3 parallel, detecting step is as follows:
(1) blood sample cracking: by the 1:4.5 mixing by volume of anticoagulant heparin whole blood, erythrocyte cracked liquid, leave standstill 15min, then medium-speed centrifuge 10min, collect supernatant;
(2) mix ovum to educate: get 30 μ l steps 1) the dissolving with 0.2M phosphate buffer the homocysteine nucleic acid aptamer fluorescence probe reagent that homocysteine nucleic acid aptamer fluorescence probe obtains and mix of the upper cleer and peaceful 40ul that obtains, under room temperature, ovum educates 10min, obtains test fluid;
(3) fluoroscopic examination: fluorescence detector detecting step 2) the test fluid 50ul that obtains, after fluorescence detector fluorescence excitation, to read after fluorescence excitation in 20 to the 100ns time period wavelength at the fluorescent value of 480 ~ 500nm;
(4) result calculates: use biomedical mapping software, with reference to the typical curve that homocysteine standard model makes, integrating step 3) in the fluorescent value that detects calculate the concentration of homocysteine in blood sample.
3 replicate determination errors of sample are 0.08 ± 0.01%.
Embodiment 7
After agent formulations dissolving prepares needed for embodiment in table 17, be distributed into bottle, carry out freeze drying, make powdered reagent; Before using, add ultrapure water, use after redissolving.Each sample set 3 parallel, detecting step is as follows:
(1) blood sample cracking: by the 1:3.0 mixing by volume of peripheral blood, erythrocyte cracked liquid, leave standstill 18min, then medium-speed centrifuge 8min, collect supernatant;
(2) mix ovum to educate: get 50 μ l steps 1) the dissolving with 0.2M phosphate buffer the homocysteine nucleic acid aptamer fluorescence probe reagent that homocysteine nucleic acid aptamer fluorescence probe obtains and mix of the upper cleer and peaceful 20ul that obtains, under room temperature, ovum educates 12min, obtains test fluid;
(3) fluoroscopic examination: fluorescence detector detecting step 2) the test fluid 50ul that obtains, after fluorescence detector fluorescence excitation, to read after fluorescence excitation in 20 to the 100ns time period wavelength at the fluorescent value of 480 ~ 500nm;
(4) result calculates: use biomedical mapping software, with reference to the typical curve that homocysteine standard model makes, integrating step 3) in the fluorescent value that detects calculate the concentration of homocysteine in blood sample.
3 replicate determination errors of sample are 0.1 ± 0.01%.
Embodiment 8
After agent formulations dissolving prepares needed for embodiment in table 18, be distributed into bottle, carry out freeze drying, make powdered reagent; Before using, add ultrapure water, use after redissolving.Each sample set 3 parallel, detecting step is as follows:
(1) blood sample cracking: by the 1:2.0 mixing by volume of peripheral blood, erythrocyte cracked liquid, leave standstill 26min, then medium-speed centrifuge 6min, collect supernatant;
(2) mix ovum to educate: get 60 μ l steps 1) the dissolving with 0.2M phosphate buffer the homocysteine nucleic acid aptamer fluorescence probe reagent that homocysteine nucleic acid aptamer fluorescence probe obtains and mix of the upper cleer and peaceful 25ul that obtains, under room temperature, ovum educates 13min, obtains test fluid;
(3) fluoroscopic examination: fluorescence detector detecting step 2) the test fluid 50ul that obtains, after fluorescence detector fluorescence excitation, to read after fluorescence excitation in 20 to the 100ns time period wavelength at the fluorescent value of 480 ~ 500nm;
(4) result calculates: use biomedical mapping software, with reference to the typical curve that homocysteine standard model makes, integrating step 3) in the fluorescent value that detects calculate the concentration of homocysteine in blood sample.
3 replicate determination errors of sample are 0.02 ± 0.01%.
Embodiment 9
After agent formulations dissolving prepares needed for embodiment in table 19, be distributed into bottle, carry out freeze drying, make powdered reagent; Before using, add ultrapure water, use after redissolving.Each sample set 3 parallel, detecting step is as follows:
(1) blood sample cracking: by the 1:4.0 mixing by volume of peripheral blood, erythrocyte cracked liquid, leave standstill 8min, then medium-speed centrifuge 7min, collect supernatant;
(2) mix ovum to educate: get 40 μ l steps 1) the dissolving with 0.2M phosphate buffer the homocysteine nucleic acid aptamer fluorescence probe reagent that homocysteine nucleic acid aptamer fluorescence probe obtains and mix of the upper cleer and peaceful 35ul that obtains, under room temperature, ovum educates 15min, obtains test fluid;
(3) fluoroscopic examination: fluorescence detector detecting step 2) the test fluid 50ul that obtains, after fluorescence detector fluorescence excitation, to read after fluorescence excitation in 20 to the 100ns time period wavelength at the fluorescent value of 480 ~ 500nm;
(4) result calculates: use biomedical mapping software, with reference to the typical curve that homocysteine standard model makes, integrating step 3) in the fluorescent value that detects calculate the concentration of homocysteine in blood sample.
3 replicate determination errors of sample are 0.01 ± 0.01%.
Claims (9)
1., based on a homocysteine kit for nucleic acid aptamer fluorescence probe, it is characterized in that, principal ingredient comprises: containing NH
4cl, Tris, EDTA-Na
2erythrocyte cracked liquid; Containing MgCl
20.2M phosphate buffer; Homocysteine standard items; Homocysteine nucleic acid aptamer fluorescence probe; Described homocysteine nucleic acid aptamer fluorescence probe is the nucleotide single-chain of 5' and 3' two ends difference mark fluorescent pyrene molecule monomer, this nucleotide single-chain sequence is any sequence dna fragment in SEQ ID NO:1 ~ SEQ ID NO:5, and its sequence is: ggcactgtac ggctaagttc ccggatagtg gattggaact ggcataaccc.
2. a kind of homocysteine kit based on nucleic acid aptamer fluorescence probe according to claim 1, is characterized in that, described containing NH
4cl, Tris, EDTA-Na
2erythrocyte cracked liquid for containing 1 ~ 280 mmol/L NH
4cl, 1 ~ 34 mmol/L Tris, 1 ~ 2mmol/LEDTA-Na
2, pH 7.0 ~ 7.2; Described containing MgCl
20.2M phosphate buffer for containing 1 ~ 10mmol/L MgCl
2.
3. a kind of homocysteine kit based on nucleic acid aptamer fluorescence probe according to claim 1 and 2, is characterized in that, described containing NH
4cl, Tris, EDTA-Na
2erythrocyte cracked liquid, containing MgCl
20.2M phosphate buffer, homocysteine standard items, homocysteine nucleic acid aptamer fluorescence probe be the dry powder preparing the liquid reagent that directly uses or need before using to be dissolved in water.
4., according to a kind of homocysteine kit based on nucleic acid aptamer fluorescence probe described in claim 1 ~ 3, it is characterized in that, this kit is for detecting the homotype semicystinol concentration investigating in anticoagulant heparin whole blood or peripheral blood.
5. detect a method for homotype semicystinol concentration investigating with the arbitrary described homocysteine kit based on nucleic acid aptamer fluorescence probe of right 1 ~ 3, it is characterized in that, method step comprises:
(1) blood sample cracking: by blood sample with containing NH
4cl, Tris, EDTA-Na
2erythrocyte cracked liquid press the mixing of 1:0.5 ~ 5 volume ratios, leave standstill 5 ~ 30min, then medium-speed centrifuge 5 ~ 10min, collect supernatant;
(2) mix ovum to educate: get the use of supernatant that 20 ~ 100 μ l step 1) obtain and 30 ~ 50ul containing MgCl
20.2M phosphate buffer, dissolve the homocysteine nucleic acid aptamer fluorescence probe reagent mixing that homocysteine nucleic acid aptamer fluorescence probe obtains, under room temperature, ovum educates 5 ~ 15min, homocysteine nucleic acid aptamer fluorescence probe is fully combined with blood sample, obtains test fluid;
(3) fluoroscopic examination: fluorescence detector detecting step 2) the test fluid 50ul that obtains, after fluorescence detector fluorescence excitation, to read after fluorescence excitation in 20 to the 100ns time period wavelength at the fluorescent value of 480 ~ 500nm;
(4) result calculates: use biomedical mapping software, with reference to the typical curve that homocysteine standard model makes, integrating step 3) in the fluorescent value that detects calculate the concentration of homocysteine in blood sample.
6. a kind of method detecting homotype semicystinol concentration investigating with the homocysteine kit based on nucleic acid aptamer fluorescence probe according to claim 5, it is characterized in that, in described homocysteine nucleic acid aptamer fluorescence probe reagent, homocysteine nucleic acid aptamer fluorescence probe concentration is 200 ~ 400 nmol/L, described homocysteine nucleic acid aptamer fluorescence probe is the nucleotide single-chain of 5' and 3' two ends difference mark fluorescent pyrene molecule monomer, this nucleotide single-chain sequence is: ggcactgtac ggctaagttc ccggatagtg gattggaact ggcataaccc.
7. a kind of method detecting homotype semicystinol concentration investigating with the homocysteine kit based on nucleic acid aptamer fluorescence probe according to claim 6, it is characterized in that, described homocysteine nucleic acid aptamer fluorescence probe not with homocysteine in conjunction with time, aptamer is in more open structure, the pyrene molecule monomer at 5' and 3' two ends dissociates mutually, and after fluorescence excitation, emission wavelength is between 370 ~ 400nm; Described homocysteine nucleic acid aptamer fluorescence probe and homocysteine in conjunction with time, homocysteine induces its recurring structure to change, the pyrene molecule monomer at aptamer 5' and 3' two ends is close to each other, form excited state dimer, after fluorescence excitation, excited state dimer emission wavelength is between 480 to 500nm.
8. a kind of method detecting homotype semicystinol concentration investigating with the homocysteine kit based on nucleic acid aptamer fluorescence probe according to claim 5, it is characterized in that, described blood sample is anticoagulant heparin whole blood or peripheral blood, described containing NH
4cl, Tris, EDTA-Na
2erythrocyte cracked liquid for containing 1 ~ 280 mmol/L NH
4cl, 1 ~ 34 mmol/L Tris, 1 ~ 2mmol/LEDTA-Na
2, pH 7.0 ~ 7.2; Described containing MgCl
20.2M phosphate buffer for containing 1 ~ 10mmol/L MgCl
2; Described fluorescence detector is the fluorescence detector with time-resolved fluorometry.
9. according to a kind of method detecting homotype semicystinol concentration investigating with the homocysteine kit based on nucleic acid aptamer fluorescence probe described in claim 5 ~ 7, it is characterized in that, this detection method is for detecting the homotype semicystinol concentration investigating in anticoagulant heparin whole blood or peripheral blood.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410717094.4A CN104597008B (en) | 2014-11-30 | 2014-11-30 | Homocysteine kit based on aptamer fluorescent probe HCy3 and detection method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410717094.4A CN104597008B (en) | 2014-11-30 | 2014-11-30 | Homocysteine kit based on aptamer fluorescent probe HCy3 and detection method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104597008A true CN104597008A (en) | 2015-05-06 |
| CN104597008B CN104597008B (en) | 2017-02-01 |
Family
ID=53122929
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410717094.4A Expired - Fee Related CN104597008B (en) | 2014-11-30 | 2014-11-30 | Homocysteine kit based on aptamer fluorescent probe HCy3 and detection method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104597008B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104597246A (en) * | 2014-11-30 | 2015-05-06 | 陈燕婷 | Homocysteine kit based on aptamer fluorescence probe HCy2 and detection method thereof |
| CN108982461A (en) * | 2018-09-04 | 2018-12-11 | 华东师范大学 | A kind of time resolution type fluorescent optical sensor and its preparation method and application |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5322795A (en) * | 1992-06-23 | 1994-06-21 | Merck & Co., Inc. | HPLC assay for the selective resolution of recombinant proteins |
| US20100209938A1 (en) * | 2009-02-06 | 2010-08-19 | Moss Fraser J | Methods and systems for detection of stoichiometry by forster resonance energy transfer |
| CN102183495A (en) * | 2011-01-26 | 2011-09-14 | 鲁东大学 | Fluorescence detection method of cysteine |
| CN102901720A (en) * | 2012-09-27 | 2013-01-30 | 中国人民解放军军事医学科学院基础医学研究所 | Method for detecting blood homocysteine and kit |
| CN103755672A (en) * | 2014-01-26 | 2014-04-30 | 大连理工常熟研究院有限公司 | Specific fluorescence probe for identifying cysteine and application thereof |
| CN103788076A (en) * | 2014-01-22 | 2014-05-14 | 山西大学 | Reagent and method for detecting cysteine |
-
2014
- 2014-11-30 CN CN201410717094.4A patent/CN104597008B/en not_active Expired - Fee Related
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5322795A (en) * | 1992-06-23 | 1994-06-21 | Merck & Co., Inc. | HPLC assay for the selective resolution of recombinant proteins |
| US20100209938A1 (en) * | 2009-02-06 | 2010-08-19 | Moss Fraser J | Methods and systems for detection of stoichiometry by forster resonance energy transfer |
| CN102183495A (en) * | 2011-01-26 | 2011-09-14 | 鲁东大学 | Fluorescence detection method of cysteine |
| CN102901720A (en) * | 2012-09-27 | 2013-01-30 | 中国人民解放军军事医学科学院基础医学研究所 | Method for detecting blood homocysteine and kit |
| CN103788076A (en) * | 2014-01-22 | 2014-05-14 | 山西大学 | Reagent and method for detecting cysteine |
| CN103755672A (en) * | 2014-01-26 | 2014-04-30 | 大连理工常熟研究院有限公司 | Specific fluorescence probe for identifying cysteine and application thereof |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104597246A (en) * | 2014-11-30 | 2015-05-06 | 陈燕婷 | Homocysteine kit based on aptamer fluorescence probe HCy2 and detection method thereof |
| CN108982461A (en) * | 2018-09-04 | 2018-12-11 | 华东师范大学 | A kind of time resolution type fluorescent optical sensor and its preparation method and application |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104597008B (en) | 2017-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104597246B (en) | Homocysteine test kit and detection method thereof based on nucleic acid aptamer fluorescence probe HCy2 | |
| Chen et al. | G-quadruplex-based detection of glyphosate in complex biological systems by a time-resolved luminescent assay | |
| CN101717814A (en) | Liquid double reagent diagnostic reagent kit for determining content of potassium ions in serum and blood plasma | |
| CN105548109A (en) | A fluorescence detecting system for heavy metal cadmium and a fluorescence detecting method | |
| CN102645420B (en) | Method for detecting multiple harmful substance residual components in food based on surface plasma resonance technique | |
| CN105044055B (en) | The detection method and protein detection sensor array of a kind of protein | |
| Guo et al. | Direct visualization of sub-femtomolar circulating microRNAs in serum based on the duplex-specific nuclease-amplified oriented assembly of gold nanoparticle dimers | |
| CN110044855A (en) | Amboceptor time resolution time-resolved fluorescence Resonance Energy Transfer | |
| CN102680442A (en) | Method for detecting trypsin using unmarked fluorescence | |
| CN104597007B (en) | Homocysteine kit based on aptamer fluorescence probe HCy5 and detection method thereof | |
| CN104597008B (en) | Homocysteine kit based on aptamer fluorescent probe HCy3 and detection method thereof | |
| CN104677868A (en) | Homocysteine (HCy) kit based on aptamer fluorescence probe and detection method for concentration of homocysteine (HCy) by using homocysteine (HCy) kit | |
| CN105606582A (en) | Alpha fetoprotein kit based on aptamer fluorescent probe AFP4 and detection method thereof | |
| CN102967708A (en) | Homogeneous immunoassay based method for synchronous fluorescence detection of multiple disease markers | |
| CN104046682B (en) | The detection method of homocysteine and diagnostic kit thereof | |
| CN104568867A (en) | Homocysteine (HCy) kit based on aptamer fluorescent probe, and detection method of HCy kit | |
| CN104569374A (en) | Homogeneous fluorescence immunoassay-based reagent group capable of rapidly and quantitatively detecting C-reactive proteins and preparation method of homogeneous fluorescence immunoassay-based reagent group | |
| CN107907515A (en) | One kind detection glutathione probe reagent box and its detection method | |
| CN101477059A (en) | Method for rapidly detecting inorganic phosphorus in water solution | |
| CN102998289B (en) | Glycosylated hemoglobin kit based on nucleic acid aptamer fluorescence probe and detection method thereof | |
| CN107941766A (en) | Glutathione kit and its detection method are measured using nucleic acid aptamer fluorescence probe | |
| CN107941767A (en) | Glutathione kit and its detection method based on nucleic acid aptamer fluorescence probe GSH2 | |
| CN105755097B (en) | Anti-leukocythemia liveness ingredient and its determining target calibration method in screening indigo naturalis comprehensively | |
| CN108226520A (en) | A kind of CK-MB detection kits, method of preparation and use based on bimolecular fluorescence complementary technology | |
| CN106645053A (en) | INS3 insulin kit based on high-sensitivity aptamer fluorescence probe and detecting method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| CB03 | Change of inventor or designer information |
Inventor after: Ge Tao Inventor after: Zhang Yinling Inventor after: Li Chunyu Inventor before: Chen Yanting Inventor before: Zhang Shenman Inventor before: Li Hongmei |
|
| COR | Change of bibliographic data | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20161209 Address after: 316199 Zhoushan, Putuo District, Donggang street, Pu Pu Road, No. 125, north of the floor of the mall floor, floor, floor, floor, room 304, room 3, No. 305, room Applicant after: ZHOUSHAN BOFU MEDICAL EXAMINATION INSTITUTE CO.,LTD. Address before: 530022 Nanning National Road, the Guangxi Zhuang Autonomous Region, No. 89 Applicant before: Chen Yanting Applicant before: Zhang Shenman Applicant before: Li Hongmei |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CP03 | Change of name, title or address |
Address after: 310000 room 172, South Tower, 97 Huhua Road, Jianggan District, Hangzhou, Zhejiang Patentee after: Hangzhou Jing Yi Technology Co.,Ltd. Address before: Room 304, 305, 3rd floor east of Taiwanese Trade Mall, 125 Xingpu Avenue, Donggang Street, Putuo District, Zhoushan City, Zhejiang Province Patentee before: ZHOUSHAN BOFU MEDICAL EXAMINATION INSTITUTE CO.,LTD. |
|
| CP03 | Change of name, title or address | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20201209 Address after: Room 213, building 2, Taoyan Street Industrial Park, Yuecheng District, Shaoxing City, Zhejiang Province Patentee after: SHAOXING BAOAO'NI TECHNOLOGY Co.,Ltd. Address before: 310000 room 172, South Tower, 97 Huhua Road, Jianggan District, Hangzhou, Zhejiang Patentee before: Hangzhou Jing Yi Technology Co.,Ltd. |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20210409 Address after: 310000 room 172, South Tower, 97 Huhua Road, Jianggan District, Hangzhou, Zhejiang Patentee after: Hangzhou Jing Yi Technology Co.,Ltd. Address before: Room 213, building 2, Taoyan Street Industrial Park, Yuecheng District, Shaoxing City, Zhejiang Province Patentee before: SHAOXING BAOAO'NI TECHNOLOGY Co.,Ltd. |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20220927 Address after: Room 3-2, Building 3-2, No. 97 Guanyin Lane, Tashan Street, Yuecheng District, Shaoxing City, Zhejiang Province, 312099 Patentee after: Shaoxing Biotide Technology Co.,Ltd. Address before: 310000 room 172, South Tower, 97 Huhua Road, Jianggan District, Hangzhou, Zhejiang Patentee before: Hangzhou Jing Yi Technology Co.,Ltd. |
|
| TR01 | Transfer of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20170201 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |